Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

DEBATE-statistical analysis plans for observational studies

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approach

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Using Trial Sequential Analysis for estimating the sample sizes of further trials: example using smoking cessation intervention

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. International severe asthma registry (ISAR): protocol for a global registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: All clinical research benefits from transparency and validity. Transparency and validity of studies may increase by prospective registration of protocols and by publication of statistical analysis plans (SAPs) before data have been accessed to discern data-driven analyses from pre-planned analyses.

MAIN MESSAGE: Like clinical trials, recommendations for SAPs for observational studies increase the transparency and validity of findings. We appraised the applicability of recently developed guidelines for the content of SAPs for clinical trials to SAPs for observational studies. Of the 32 items recommended for a SAP for a clinical trial, 30 items (94%) were identically applicable to a SAP for our observational study. Power estimations and adjustments for multiplicity are equally important in observational studies and clinical trials as both types of studies usually address multiple hypotheses. Only two clinical trial items (6%) regarding issues of randomisation and definition of adherence to the intervention did not seem applicable to observational studies. We suggest to include one new item specifically applicable to observational studies to be addressed in a SAP, describing how adjustment for possible confounders will be handled in the analyses.

CONCLUSION: With only few amendments, the guidelines for SAP of a clinical trial can be applied to a SAP for an observational study. We suggest SAPs should be equally required for observational studies and clinical trials to increase their transparency and validity.

Original languageEnglish
Article number233
JournalBMC Medical Research Methodology
Volume19
Issue number1
Pages (from-to)233
ISSN1471-2288
DOIs
Publication statusPublished - 9 Dec 2019

ID: 58626638